Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by Ekso Bionics Holdings, Inc. on June 7, 2018, in Richmond, California. The filing details the results of six proposals submitted to security holders. The registrant is identified as an emerging growth company.
Key Financial Metrics
This filing is a current report regarding corporate governance and shareholder voting. It does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The text contains no financial statements or operational results.
Material Changes and Voting Results
The filing documents the outcomes of shareholder votes on six key proposals. A quorum was established with 48,698,757 shares present out of 60,354,941 outstanding.
- Proposal 1 (Director Election): All six nominees (Steven Sherman, Jack Peurach, Ted Wang, Marilyn Hamilton, Charles Li, and Stanley Stern) were elected. Broker non-votes were significant (23,295,096) for all candidates.
- Proposal 2 (Authorized Shares): Ratified the amendment to increase authorized common stock from 71,428,571 to 141,428,571 shares. Passed with 41,224,976 votes for versus 6,931,910 against.
- Proposal 3 (Equity Incentive Plan): Ratified the amendment to increase shares available for grant under the 2014 Equity Incentive Plan from 4,714,285 to 9,114,285 shares. Passed with 24,074,890 votes for versus 1,228,271 against.
- Proposal 4 (Auditor Ratification): Ratified the appointment of OUM & Co., LLP as independent auditors for the year ending December 31, 2018. Passed with 46,838,674 votes for versus 1,289,354 against.
- Proposal 5 (Say-on-Pay): Approved the advisory vote on executive compensation. Passed with 24,245,690 votes for versus 873,209 against.
- Proposal 6 (Say-on-Pay Frequency): Stockholders voted for an annual advisory vote on executive compensation. The "One Year" option received 24,294,820 votes, significantly outpacing the "Two Years" (499,849) and "Three Years" (381,254) options.
Guidance, Outlook, and Management Commentary
Management noted that, consistent with the majority preference expressed in Proposal 6, the Board of Directors determined to include an advisory stockholder vote on executive compensation annually until the next required frequency vote, which must occur no later than the 2024 Annual Meeting. No financial guidance, risk factors, or contingencies were disclosed in this specific filing.
Important Facts for Investor Verification
- Verify the impact of the increased authorized share count (Proposal 2) on potential future dilution.
- Confirm the details of the expanded Equity Incentive Plan (Proposal 3) and its effect on share-based compensation expenses.
- Note the high volume of broker non-votes (approx. 23.3 million) on director elections and compensation proposals, indicating significant shares held in street name where brokers lacked discretionary voting power.
- Confirm the appointment of OUM & Co., LLP as the independent auditor for the fiscal year ending December 31, 2018.